BAX- Baxter International Inc.
Healthcare · Medical Instruments & Supplies
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
HoldWall Street consensus from 11 analysts
12-Month Price Target
$28.73
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $23.86
Graham Number
√(22.5 × EPS × Book Value)
N/A
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$16.52
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
7/10
70% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
-14.4%Return on equity - measures how efficiently capital is used
Positive profit margin
-9.3%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+5.3%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+36.8%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
156.45×Low financial leverage reduces risk of distress
Current ratio above 1
1.95×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$152M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
0.17%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Oct 29, 2026
44
days
EPS (TTM)
$-1.88
P/E (TTM)
-
Fwd P/E
11.7
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
0.17%
5Y Avg Annual
$0.7800
Last Payment
$0.0100
Ex-Date
08/28/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest08/28/2026 | 10/01/2026 | $0.0100 | 0.17% |
05/29/2026 | 07/02/2026 | $0.0100 | 0.17% |
02/27/2026 | 04/02/2026 | $0.0100 | 0.17% |
11/28/2025 | 01/01/2026 | $0.0100 | 0.17% |
08/29/2025 | 10/02/2025 | $0.1700 | 2.85% |
05/30/2025 | 07/03/2025 | $0.1700 | 2.85% |
02/28/2025 | 04/03/2025 | $0.1700 | 2.85% |
11/29/2024 | 01/02/2025 | $0.1700 | 2.85% |
Magic Number
Shares needed to self-fund your next purchase
$23.86
Price
$0.0100
Last div. (quarterly)
2,386
shares
Own 2,386 BAX shares ($56,929.96) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$56,929.96
New shares / year
+4 shares
Dividend Calculator
0.17% yieldEstimate BAX dividend income at the current rate.
Per year
$16.76
Per month
$1.4
≈ 419.1 shares at $0.04/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
BAX vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Location
Deerfield, United States
Employees
37,500
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Baxter International Inc. (BAX) stock trades at $23.86, up 0.25% on the day. With a market capitalization of $12.34 billion, BAX is a large-cap healthcare stock. It trades at a forward P/E of 11.7 and earnings per share (EPS) of $-1.88. Over the most recent period the company reported 5% year-over-year revenue growth and a net profit margin of -9.3%. Below you'll find BAX's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
BAX - Frequently Asked Questions
Is Baxter International Inc. (BAX) a good stock to buy in 2026?
Baxter International Inc. (BAX) shows risks such as negative profit margins and high leverage (debt/equity of 156.4). Whether BAX is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is BAX's stock price today?
Baxter International Inc. (BAX) trades at $23.86, up 0.25% on the session. Prices on this page update throughout the trading day.
Does BAX pay a dividend?
Yes. Baxter International Inc. pays an annual dividend of $0.04 per share, a dividend yield of 0.17%. The most recent ex-dividend date was August 28, 2026. Its payout ratio is about 308% of earnings.
What is BAX's market cap?
Baxter International Inc. (BAX) has a market capitalization of $12.34 billion, classifying it as a large-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.